AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / SPONSORED ADR
Total 13F shares
1,458,043
Share change
-1,450,991
Total reported value
$2,535,000
Price per share
$1.74
Number of holders
12
Value change
-$2,566,221
Number of buys
5
Number of sells
13

Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q3 2020

As of 30 Sep 2020, AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,458,043 shares. The largest 10 holders included NEA Management Company, LLC, Omnia Family Wealth, LLC, United Asset Strategies, Inc., RENAISSANCE TECHNOLOGIES LLC, Hikari Power Ltd, HRT FINANCIAL LP, WEDBUSH SECURITIES INC, HighTower Advisors, LLC, The PNC Financial Services Group, Inc., and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.